These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of ACTH4-9 analog (Org2766) on some cerebrospinal fluid parameters in patients with Alzheimer's disease. Jolkkonen JT; Soininen HS; Riekkinen PJ Life Sci; 1985 Aug; 37(7):585-90. PubMed ID: 2991689 [TBL] [Abstract][Full Text] [Related]
3. Acetylcholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Soininen H; Halonen T; Riekkinen PJ Acta Neurol Scand; 1981 Sep; 64(3):217-24. PubMed ID: 7315192 [TBL] [Abstract][Full Text] [Related]
4. Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls. Hartikainen P; Reinikainen KJ; Soininen H; Sirviö J; Soikkeli R; Riekkinen PJ J Neural Transm Park Dis Dement Sect; 1992; 4(1):53-68. PubMed ID: 1347220 [TBL] [Abstract][Full Text] [Related]
5. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type. Appleyard ME; McDonald B J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1074-8. PubMed ID: 1469405 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study. Zubenko GS; Marquis JK; Volicer L; Direnfeld LK; Langlais PJ; Nixon RA Biol Psychiatry; 1986 Dec; 21(14):1365-81. PubMed ID: 3024746 [TBL] [Abstract][Full Text] [Related]
8. The effect of pentylenetetrazol on the levels of dopamine-beta-hydroxylase in the cerebrospinal fluid of rabbits: a dose-dependent relationship. De Roeck J; van Bockstaele M; De Potter WP Neurosci Lett; 1983 Jan; 35(1):65-70. PubMed ID: 6843891 [TBL] [Abstract][Full Text] [Related]
10. Dopamine-beta-hydroxylase activities in serum and cerebrospinal fluid of aged and demented patients. Miyata S; Nagata H; Yamao S; Nakamura S; Kameyama M J Neurol Sci; 1984 Mar; 63(3):403-9. PubMed ID: 6726279 [TBL] [Abstract][Full Text] [Related]
11. Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease. Sirviö J; Kutvonen R; Soininen H; Hartikainen P; Riekkinen PJ J Neural Transm; 1989; 75(2):119-27. PubMed ID: 2918304 [TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia. Nakano S; Kato T; Nakamura S; Kameyama M J Neurol Sci; 1986 Sep; 75(2):213-23. PubMed ID: 3760912 [TBL] [Abstract][Full Text] [Related]
13. Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer disease. Elble R; Giacobini E; Scarsella GF Arch Neurol; 1987 Apr; 44(4):403-7. PubMed ID: 3827696 [TBL] [Abstract][Full Text] [Related]
14. The effect of pentylenetetrazol on dopamine-beta-hydroxylase and acetylcholinesterase activities in the cerebrospinal fluid of rabbits. A contribution to its mechanism of action. De Roeck J; Van Bockstaele M; De Potter WP Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):324-5. PubMed ID: 7181592 [No Abstract] [Full Text] [Related]
15. Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type. Tune L; Gucker S; Folstein M; Oshida L; Coyle JT Ann Neurol; 1985 Jan; 17(1):46-8. PubMed ID: 3985585 [TBL] [Abstract][Full Text] [Related]
16. Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. O'Connor DT; Cervenka JH; Stone RA; Levine GL; Parmer RJ; Franco-Bourland RE; Madrazo I; Langlais PJ; Robertson D; Biaggioni I Clin Sci (Lond); 1994 Feb; 86(2):149-58. PubMed ID: 8143425 [TBL] [Abstract][Full Text] [Related]
17. Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Appleyard ME; Smith AD; Berman P; Wilcock GK; Esiri MM; Neary D; Bowen DM Brain; 1987 Oct; 110 ( Pt 5)():1309-22. PubMed ID: 3676702 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type. Atack JR; May C; Kaye JA; Kay AD; Rapoport SI Ann Neurol; 1988 Feb; 23(2):161-7. PubMed ID: 3377438 [TBL] [Abstract][Full Text] [Related]
19. Somatostatin-like immunoreactivity and acetylcholinesterase activities in cerebrospinal fluid of patients with Alzheimer disease and senile dementia of the Alzheimer type. Gomez S; Davous P; Rondot P; Faivre-Bauman A; Valade D; Puymirat J Psychoneuroendocrinology; 1986; 11(1):69-73. PubMed ID: 3517922 [TBL] [Abstract][Full Text] [Related]
20. Decreased cerebrospinal fluid acetylcholinesterase in patients with subcortical ischemic vascular dementia. Wallin A; Sjögren M; Blennow K; Davidsson P Dement Geriatr Cogn Disord; 2003; 16(4):200-7. PubMed ID: 14512714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]